Health
Results: 2209-2220 of 8721

BP, Cabot Credit Management, and Puma Capital Group Join as Sponsors for Pearn Kandola's Psychological Safety Week

European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

New YouGov data finds 1 in 3 Brits may be at risk of B12 deficiency - but most have no idea. Many mistake symptoms for stress or ageing, says Nature Provides








